Mitogen-activated protein kinase phosphatase 1 disrupts proinflammatory protein synthesis in endotoxin-adapted monocytes

Clinical and Vaccine Immunology

Volumn 20, Issue 9, 2013, Pages 1396-1404

  Brudecki, Laura ^a   Ferguson, Donald A ^b   McCall, Charles E ^a   Gazzar, Mohamed El ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MICRORNA 146A; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; RNA BINDING PROTEIN; RNA BINDING PROTEIN MOTIF 4; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; AUTOREGULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; ENZYME INACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; INTRACELLULAR SIGNALING; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; SEPSIS; TRANSLATION REGULATION;

CELL LINE; DUAL SPECIFICITY PHOSPHATASE 1; ENDOTOXINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-6; MICRORNAS; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BIOSYNTHESIS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884686807     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00264-13     Document Type: Article

References (54)

1. Hotchkiss RS, Karl IE. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-150.
2. McCall CE, Yoza BK. 2007. Gene silencing in severe systemic inflammation. Am. J. Respir. Crit. Care Med. 175:763-767.
3. Remick DG. 2007. Pathophysiology of sepsis. Am. J. Pathol. 170:1435-1444.
4. Cavaillon JM, Adib-Conquy M. 2006. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 10:233. doi:10.1186/cc5055.
5. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. 2009. The sepsis seesaw: tilting toward immunosuppression. Nat. Med. 15:496-497.
6. McCall CE, Yoza B, Liu T, El Gazzar M. 2010. Gene-specific epigenetic regulation in serious infections with systemic inflammation. J. Innate Immun. 2:395-405.
7. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. 2003. Cytokine cascade in sepsis. Scand. J. Infect. Dis. 35:535-544.
8. Sriskandan S, Altmann DM. 2008. The immunology of sepsis. J. Pathol. 214:211-223.
9. Ghisletti S, Huang W, Jepsen K, Benner C, Hardiman G, Rosenfeld MG, Glass CK. 2009. Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and antiinflammatory signaling pathways. Genes Dev. 23:681-693.
10. Takeda K, Akira S. 2004. TLR signaling pathways. Semin. Immunol. 16:3-9.
11. Chan C, Li L, McCall CE, Yoza BK. 2005. Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. J. Immunol. 175:461-468.
12. El Gazzar M, Yoza BK, Hu JY, Cousart SL, McCall CE. 2007. Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. J. Biol. Chem. 282:26857-26864.
13. El Gazzar M, Yoza BK, Chen X, Hu J, Hawkins GA, McCall CE. 2008. G9a and HP1 couple histone and DNA methylation to TNFalpha transcription silencing during endotoxin tolerance. J. Biol. Chem. 283:32198-32208.
14. El Gazzar M, Yoza BK, Chen X, Garcia BA, Young NL, McCall CE. 2009. Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance. Mol. Cell. Biol. 29:1959-1971.
15. West MA, Heagy W. 2002. Endotoxin tolerance: a review. Crit. Care Med. 30(1 Suppl):S64-S73.
16. Brudecki L, Ferguson DA, McCall CE, El Gazzar M. 2012. Myeloidderived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect. Immun. 80:2026-2034.
17. Munoz C, Misset B, Fitting C, Bleriot JP, Carlet J, Cavaillon JM. 1991. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur. J. Immunol. 21:2177-2184.
18. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL. 1993. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J. Clin. Invest. 91:853-861.
19. Biswas SK, Lopez-Collazo E. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30:475-487.
20. Fan H, Cook JA. 2004. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10:71-84.
21. LaRue KE, McCall CE. 1994. A labile transcriptional repressor modulates endotoxin tolerance. J. Exp. Med. 180:2269-2275.
22. El Gazzar M, McCall CE. 2010. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J. Biol. Chem. 285:20940-20951.
23. Mueller LP, Yoza BK, Neuhaus K, Loeser CS, Cousart S, Chang MC, Meredith JW, Li L, McCall CE. 2001. Endotoxin-adapted septic shock leukocytes selectively alter production of sIL-1RA and IL-1beta. Shock 16:430-437.
24. Nahid MA, Pauley KM, Satoh M, Chan EK. 2009. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J. Biol. Chem. 284:34590-34599.
25. El Gazzar M, Church A, Liu T, McCall CE. 2011. MicroRNA-146a regulates both transcription silencing and translation disruption of TNFalpha during TLR4-induced gene reprogramming. J. Leukoc. Biol. 90: 509-519.
26. Heagy W, Hansen C, Nieman K, Rodriguez JL, West MA. 2000. Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-tolerant human monocytes. J. Trauma 49:806-814.
27. Li L, Cousart S, Hu J, McCall CE. 2000. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275:23340-23345.
28. Su B, Karin M. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8:402-411.
29. Dong C, Davis RJ, Flavell RA. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20:55-72.
30. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ. 2006. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol. Cell. Biol. 26: 9196-9208.
31. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T. 2006. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176:1899-1907.
32. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR. 1994 A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
33. Carballo E, Lai WS, Blackshear PJ. 1998. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281:1001-1005.
34. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21:6461-6469.
35. Chen P, Li J, Barnes J, Kokkonen GC, Lee JC, Liu Y. 2002. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 169:6408-6416.
36. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1:94-97.
37. Nimah M, Zhao B, Denenberg AG, Bueno O, Molkentin J, Wong HR, Shanley TP. 2005. Contribution of MKP-1 regulation of p38 to endotoxin tolerance. Shock 23:80-87.
38. Li L, Chen SF, Liu Y. 2009. MAP kinase phosphatase-1, a critical negative regulator of the innate immune response. Int. J. Clin. Exp. Med. 2:48-67.
39. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, Baliga RS, Meng X, Smith CV, Bauer JA, Chang CH, Liu Y. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203:131-140.
40. Taganov KD, Boldin MP, Chang KJ, Baltimore D. 2006. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103:12481-12486.
41. Lin JC, Hsu M, Tarn WY. 2007. Cell stress modulates the function of splicing regulatory protein RBM4 in translation control. Proc. Natl. Acad. Sci. U. S. A. 104:2235-2240.
42. Lin JC, Tarn WY. 2009. RNA-binding motif protein 4 translocates to cytoplasmic granules and suppresses translation via argonaute2 during muscle cell differentiation. J. Biol. Chem. 284:34658-34665.
43. McCall CE, El Gazzar M, Liu T, Vachharajani V, Yoza B. 2011. Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J. Leukoc. Biol. 90:439-446.
44. Hock J, Weinmann L, Ender C, Rudel S, Kremmer E, Raabe M, Urlaub H, Meister G. 2007. Proteomic and functional analysis of Argonautecontaining mRNA-protein complexes in human cells. EMBO Rep. 8:1052-1060.
45. Rudel S, Meister G. 2008. Phosphorylation of Argonaute proteins: regulating gene regulators. Biochem. J. 413:e7-e9.
46. Keyse SM. 2000. Protein phosphatases and the regulation of mitogenactivated protein kinase signalling. Curr. Opin. Cell Biol. 12:186-192.
47. Shanley TP. 2002. Phosphatases: counterregulatory role in inflammatory cell signaling. Crit. Care Med. 30(1 Suppl):S80-S88.
48. Hutter D, Chen P, Barnes J, Liu Y. 2000. Catalytic activation of mitogenactivated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochem. J. 352(Pt 1):155-163.
49. Perdiguero E, Sousa-Victor P, Ruiz-Bonilla V, Jardi M, Caelles C, Serrano AL, Munoz-Canoves P. 2011. p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair. J. Cell Biol. 195:307-322.
50. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J, Sun G, Tay J, Linsley PS, Baltimore D. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208:1189-1201.
51. Quinn EM, Wang JH, O'Callaghan G, Redmond HP. 2013. MicroRNA-146a is upregulated by and negatively regulates TLR2 signaling. PLoS One 8:e62232. doi:10.1371/journal.pone.0062232.
52. Su J, Xie Q, Wilson I, Li L. 2007. Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signaling. Cell. Signal. 19:1596-1601.
53. Kobayashi K, Hernandez LD, Galan JE, Janeway CA, Jr., Medzhitov R, Flavell RA. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191-202.
54. Harada K, Isse K, Sato Y, Ozaki S, Nakanuma Y. 2006. Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M. Liver Int. 26:935-942.